title: Pharmacokinetics, pharmacodynamics, and tolerability of aleglitazar in patients with type 2 diabetes: results from a randomized, placebo-controlled clinical study.
authors.affiliation: Clinical Pharmacology, F Hoffmann-La Roche AG, Basel, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Sanwald-Ducray
authors.forename: X
authors.initials: X
authors.lastname: Liogier D'ardhuy
authors.forename: C
authors.initials: C
authors.lastname: Jamois
authors.forename: L
authors.initials: L
authors.lastname: Banken